|
CARD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.045200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.383700E-02 |
| Normal-vs-Stage2 |
7.979000E-01 |
| Normal-vs-Stage3 |
1.340620E-01 |
| Normal-vs-Stage4 |
8.323700E-02 |
| Stage1-vs-Stage2 |
8.139600E-02 |
| Stage1-vs-Stage3 |
9.049000E-01 |
| Stage1-vs-Stage4 |
4.481000E-01 |
| Stage2-vs-Stage3 |
1.618830E-01 |
| Stage2-vs-Stage4 |
1.366430E-01 |
| Stage3-vs-Stage4 |
5.801800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.587700E-02 |
| Normal-vs-AfricanAmerican |
9.393600E-01 |
| Normal-vs-Asian |
6.104400E-01 |
| Caucasian-vs-AfricanAmerican |
4.308000E-02 |
| Caucasian-vs-Asian |
7.448400E-01 |
| AfricanAmerican-vs-Asian |
7.255400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.573390E-01 |
| Normal-vs-Female |
4.732400E-01 |
| Male-vs-Female |
3.335600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.643600E-01 |
| Normal-vs-Extreme_Weight |
5.493900E-02 |
| Normal-vs-Obese |
6.935600E-01 |
| Normal-vs-Extreme_Obese |
3.009600E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.355000E-01 |
| Normal_Weight-vs-Obese |
5.851800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.020600E-01 |
| Extreme_Weight-vs-Obese |
9.043900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.064200E-01 |
| Obese-vs-Extreme_Obese |
1.254590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.230200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.167800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.064500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.483540E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.660600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.613600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.221900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.400000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.090400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.819570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.584100E-02 |
| Normal-VS-Type2 PRCC |
4.794400E-02 |
| Normal-VS-KIRP CIMP |
1.477570E-01 |
| Normal-VS-Unclassified PRCC |
4.038200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.084000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.121000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.625700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.059200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.508140E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.557400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.789800E-02 |
| Normal-vs-N1 |
8.084600E-01 |
| Normal-vs-N2 |
1.577830E-01 |
| N0-vs-N1 |
1.153360E-01 |
| N0-vs-N2 |
6.763400E-01 |
| N1-vs-N2 |
3.223600E-01 |
|
|
